Insights from Mizuho Americas
-
Category: Research
The Roadmap to 5G: The Next Frontier
Mizuho Research Analyst Vijay Rakesh looks at the race to 5G and the major changes this technology will bring.
-
Category: Research
HCM’s on Cloud Nine: A Q&A with Software Analyst Siti Panigrahi
Even while experiencing impressive growth in the past few years, SaaS companies remain a darling of the investor community. Siti Panigrahi discusses the trends influencing this popular market.
-
Category: Speaker Series
Coffee With Cassie Lee, Senior Vice President & CFO, AT&T Technology and Operations
Jim Gorman, Director of Internal Communications & Media Relations, sits down with Cassie Lee, Senior Vice President & CFO, AT&T Technology and Operations to talk about her career and how she stays on top of technology trends.
-
Category: Research
Dry Eye on the Rise
There's been little improvement in treatment for dry eye disease over the past 20 years, but biotech analyst Difei Yang says new therapies are showing promise.
-
Category: Research
Mizuho’s REIT/Real Estate Summit Recap
More than 20 REITs gathered at our conference in New York to discuss the trends and challenges in the real estate space. Here, we outline highlights from Equity Research Analyst Haendel St. Juste.
-
Category: Expert Opinions
USMCA: The Future of North American Trade
With NAFTA poised to be replaced by USMCA, the disruptions created when a continental trade agreement is renegotiated present challenges and opportunities for supply chain management, working capital, and capital expenditures.
-
Category: Research
Equity Research Analyst Mara Goldstein on the Evolving Immuno-Oncology Sector
With scientific breakthroughs in genomics, antibody discovery, and cell and gene therapies, oncology is expected to attract a bigger R&D spend globally than ever before.
-
Category: Research
The History of Cancer Care
From hopeless to hyper-targeted, Salim Syed walks us through the evolution of cancer treatments— from early surgery in ancient times to the exciting prospects for immunotherapy, targeting tell-tale neoantigen proteins that identify cancer cells.
-
Category: Trends
Mizuho Cybersecurity Summit: What the CISOs Say
We recap some of the top trends discussed at the inaugural summit, hosted by Mizuho Equity Research Analyst Gregg Moskowitz.